CL2013001609A1 - Uso de compuestos fenil o piridin sustituidos como intermediarios para la preparacion de un compuesto conjugado de dimeros de pirrolo[1,4]benzodiazepina (pbd) (divisional de la solicitud 489-2012). - Google Patents
Uso de compuestos fenil o piridin sustituidos como intermediarios para la preparacion de un compuesto conjugado de dimeros de pirrolo[1,4]benzodiazepina (pbd) (divisional de la solicitud 489-2012).Info
- Publication number
- CL2013001609A1 CL2013001609A1 CL2013001609A CL2013001609A CL2013001609A1 CL 2013001609 A1 CL2013001609 A1 CL 2013001609A1 CL 2013001609 A CL2013001609 A CL 2013001609A CL 2013001609 A CL2013001609 A CL 2013001609A CL 2013001609 A1 CL2013001609 A1 CL 2013001609A1
- Authority
- CL
- Chile
- Prior art keywords
- dimeros
- pbd
- benzodiazepine
- pyrrolo
- divisional
- Prior art date
Links
- GUJAGMICFDYKNR-UHFFFAOYSA-N 1,4-benzodiazepine Chemical compound N1C=CN=CC2=CC=CC=C12 GUJAGMICFDYKNR-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title 1
- 150000003222 pyridines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/06—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 containing at least one condensed beta-lactam ring system, provided for by groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00, e.g. a penem or a cepham system
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0904043A FR2949469A1 (fr) | 2009-08-25 | 2009-08-25 | Derives anticancereux, leur preparation et leur application en therapeutique |
| FR0904368A FR2949470B1 (fr) | 2009-08-25 | 2009-09-11 | Derives anticancereux, leur preparation et leur application therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2013001609A1 true CL2013001609A1 (es) | 2013-11-04 |
Family
ID=41720559
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2012000489A CL2012000489A1 (es) | 2009-08-25 | 2012-02-24 | Compuestos dimeros de pirrolo[2,1 c][1,4]benzodiazepin-5-ona (tomaimicina); conjugados de estos compuestos; procedimiento de preparacion de los conjugados; composicion farmaceutica que comprende a los compuestos o al conjugado; y uso de los compuestos y del conjugado como anticancerosos. |
| CL2013001609A CL2013001609A1 (es) | 2009-08-25 | 2013-06-05 | Uso de compuestos fenil o piridin sustituidos como intermediarios para la preparacion de un compuesto conjugado de dimeros de pirrolo[1,4]benzodiazepina (pbd) (divisional de la solicitud 489-2012). |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2012000489A CL2012000489A1 (es) | 2009-08-25 | 2012-02-24 | Compuestos dimeros de pirrolo[2,1 c][1,4]benzodiazepin-5-ona (tomaimicina); conjugados de estos compuestos; procedimiento de preparacion de los conjugados; composicion farmaceutica que comprende a los compuestos o al conjugado; y uso de los compuestos y del conjugado como anticancerosos. |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US8481042B2 (es) |
| EP (1) | EP2470547B1 (es) |
| JP (1) | JP5889189B2 (es) |
| KR (1) | KR20130026405A (es) |
| CN (1) | CN102753559B (es) |
| AR (1) | AR078143A1 (es) |
| AU (1) | AU2010288382B2 (es) |
| BR (1) | BR112012004146A2 (es) |
| CA (1) | CA2772102C (es) |
| CL (2) | CL2012000489A1 (es) |
| CO (1) | CO6612210A2 (es) |
| CR (1) | CR20120085A (es) |
| DO (1) | DOP2012000038A (es) |
| EA (1) | EA026488B1 (es) |
| EC (1) | ECSP12011688A (es) |
| ES (1) | ES2484690T3 (es) |
| FR (2) | FR2949469A1 (es) |
| GT (1) | GT201200046A (es) |
| HN (1) | HN2012000437A (es) |
| IL (1) | IL218262A0 (es) |
| MA (1) | MA33600B1 (es) |
| MX (1) | MX2012002434A (es) |
| MY (1) | MY157469A (es) |
| NI (1) | NI201200031A (es) |
| NZ (1) | NZ598401A (es) |
| PE (1) | PE20120992A1 (es) |
| PH (1) | PH12012500391A1 (es) |
| SG (1) | SG178537A1 (es) |
| TN (1) | TN2012000053A1 (es) |
| TW (1) | TWI477275B (es) |
| UA (1) | UA106507C2 (es) |
| UY (1) | UY32854A (es) |
| WO (1) | WO2011023883A1 (es) |
| ZA (1) | ZA201201397B (es) |
Families Citing this family (76)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2795349C (en) | 2010-04-15 | 2016-11-29 | Seattle Genetics, Inc. | Targeted pyrrolobenzodiazepine conjugates |
| JP5875083B2 (ja) | 2010-04-15 | 2016-03-02 | メディミューン リミテッド | 増殖性疾患治療用ピロロベンゾジアゼピン |
| SG11201400770SA (en) | 2011-09-20 | 2014-04-28 | Spirogen Sarl | Pyrrolobenzodiazepines as unsymmetrical dimeric pbd compounds for inclusion in targeted conjugates |
| CA2850373C (en) | 2011-10-14 | 2019-07-16 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines and targeted conjugates |
| EP2751111B1 (en) | 2011-10-14 | 2017-04-26 | MedImmune Limited | Asymmetrical bis-(5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one) derivatives for the treatment of proliferative or autoimmune diseases |
| AU2012322932B2 (en) | 2011-10-14 | 2016-11-10 | Medimmune Limited | Pyrrolobenzodiazepines |
| CN103997893B (zh) | 2011-10-14 | 2019-04-12 | 西雅图基因公司 | 吡咯并苯并二氮杂卓和靶向结合物 |
| EP2793947B1 (en) | 2011-12-23 | 2021-02-03 | Innate Pharma | Enzymatic conjugation of polypeptides |
| WO2013173337A2 (en) | 2012-05-15 | 2013-11-21 | Seattle Genetics, Inc. | Self-stabilizing linker conjugates |
| US9504756B2 (en) | 2012-05-15 | 2016-11-29 | Seattle Genetics, Inc. | Self-stabilizing linker conjugates |
| US10132799B2 (en) | 2012-07-13 | 2018-11-20 | Innate Pharma | Screening of conjugated antibodies |
| HRP20182129T1 (hr) | 2012-10-12 | 2019-02-08 | Adc Therapeutics Sa | Konjugati protutijelo - pirolobenzodiazepin |
| MX338711B (es) | 2012-10-12 | 2016-04-28 | Medimmune Ltd | Pirrolobenzodiazepinas y conjugados de las mismas. |
| JP6392765B2 (ja) | 2012-10-12 | 2018-09-19 | エイディーシー・セラピューティクス・エス・アーＡｄｃ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｓａ | ピロロベンゾジアゼピン−抗体結合体 |
| EP2906249B1 (en) | 2012-10-12 | 2018-06-27 | MedImmune Limited | Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation |
| ES2680153T3 (es) | 2012-10-12 | 2018-09-04 | Adc Therapeutics Sa | Conjugados de anticuerpos anti-PSMA-pirrolobenzodiazepinas |
| HRP20190366T1 (hr) | 2012-10-12 | 2019-04-19 | Medimmune Limited | Pirolobenzodiazepini i njihovi konjugati |
| EP2906296B1 (en) | 2012-10-12 | 2018-03-21 | ADC Therapeutics SA | Pyrrolobenzodiazepine-antibody conjugates |
| EP2906297B1 (en) | 2012-10-12 | 2017-12-06 | ADC Therapeutics SA | Pyrrolobenzodiazepine-antibody conjugates |
| RS57694B1 (sr) | 2012-10-12 | 2018-11-30 | Adc Therapeutics Sa | Pirolobenzodiazepin - anti-psma konjugati antitela |
| EP3564259A3 (en) | 2012-11-09 | 2020-02-12 | Innate Pharma | Recognition tags for tgase-mediated conjugation |
| DK2968494T3 (en) | 2013-03-13 | 2019-03-04 | Seattle Genetics Inc | ACTIVATED CARBON FILTERING FOR CLEANING BENZODIAZEPINE ADCs |
| AU2014229529B2 (en) * | 2013-03-13 | 2018-02-15 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
| TWI680766B (zh) * | 2013-03-13 | 2020-01-01 | 英商梅迪繆思有限公司 | 吡咯并苯并二氮呯及其共軛物 |
| US10611824B2 (en) | 2013-03-15 | 2020-04-07 | Innate Pharma | Solid phase TGase-mediated conjugation of antibodies |
| EP3010547B1 (en) | 2013-06-20 | 2021-04-21 | Innate Pharma | Enzymatic conjugation of polypeptides |
| CN105517577A (zh) | 2013-06-21 | 2016-04-20 | 先天制药公司 | 多肽的酶促偶联 |
| WO2015052535A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
| EP3054983B1 (en) | 2013-10-11 | 2019-03-20 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| WO2015052534A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
| GB201317981D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
| NZ758049A (en) | 2013-10-15 | 2024-03-22 | Seagen Inc | Pegylated drug-linkers for improved ligand-drug conjugate pharmacokinetics |
| SI3082878T1 (sl) | 2013-12-19 | 2023-01-31 | Seagen Inc. | Metilen-karbamatni linkerji za uporabo s tarčnimi konjugati zdravila |
| KR20230088389A (ko) | 2014-02-11 | 2023-06-19 | 씨젠 인크. | 단백질의 선택적 환원 |
| WO2016008112A1 (en) | 2014-07-16 | 2016-01-21 | Medshine Discovery Inc. | Linkers and application towards adc thereof |
| LT3191135T (lt) | 2014-09-12 | 2020-11-25 | Genentech, Inc. | Anti-her2 antikūnai ir imunokonjugatai |
| GB201416112D0 (en) * | 2014-09-12 | 2014-10-29 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| MX2017003472A (es) * | 2014-09-17 | 2017-10-31 | Genentech Inc | Inmunoconjugados que comprenden anticuerpos anti-her2. |
| CN107148285B (zh) | 2014-11-25 | 2022-01-04 | Adc治疗股份有限公司 | 吡咯并苯并二氮杂䓬-抗体缀合物 |
| BR112017014937A2 (pt) | 2015-01-14 | 2018-03-13 | Bristol-Myers Squibb Company | dímeros de benzodiazepina ligados em ponte a heteroarileno, conjugados dos mesmos, e métodos de preparação e uso |
| MX2017009145A (es) | 2015-01-14 | 2017-11-22 | Bristol Myers Squibb Co | Dimeros de benzodiazepina, conjugados de estos, y sus metodos de preparacion y uso. |
| GB201506411D0 (en) | 2015-04-15 | 2015-05-27 | Bergenbio As | Humanized anti-axl antibodies |
| GB201506402D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
| CA2990030A1 (en) | 2015-06-23 | 2016-12-29 | Bristol-Myers Squibb Company | Macrocyclic benzodiazepine dimers, conjugates thereof, preparation and uses |
| CR20180243A (es) | 2015-10-02 | 2018-07-31 | Genentech Inc | Conjugados de anticuerpo-fármaco de pirrolobenzodiazepina y métodos de uso |
| GB201601431D0 (en) | 2016-01-26 | 2016-03-09 | Medimmune Ltd | Pyrrolobenzodiazepines |
| GB201602359D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201602356D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| CN109843919A (zh) | 2016-03-25 | 2019-06-04 | 西雅图基因公司 | 用于制备聚乙二醇化的药物-接头及其中间体的方法 |
| GB201607478D0 (en) | 2016-04-29 | 2016-06-15 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| TWI851531B (zh) | 2016-08-09 | 2024-08-11 | 美商思進公司 | 具有改善之生理化學性質之具自我穩定連接子之藥物結合物 |
| GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| JP7244987B2 (ja) | 2016-12-14 | 2023-03-23 | シージェン インコーポレイテッド | 多剤抗体薬物コンジュゲート |
| CN110300765B (zh) | 2017-01-24 | 2024-08-23 | 依奈特制药公司 | Nkp46结合剂 |
| EP3577138A1 (en) | 2017-02-06 | 2019-12-11 | Innate Pharma | Immunomodulatory antibody drug conjugates binding to a human mica polypeptide |
| RS61795B1 (sr) | 2017-02-08 | 2021-06-30 | Adc Therapeutics Sa | Konjugati pirolobenzodiazepin antitela |
| GB201702031D0 (en) | 2017-02-08 | 2017-03-22 | Medlmmune Ltd | Pyrrolobenzodiazepine-antibody conjugates |
| KR102648564B1 (ko) | 2017-03-24 | 2024-03-19 | 씨젠 인크. | 글루쿠로니드 약물-링커의 제조 공정 및 그 중간물 |
| CN110582505B (zh) | 2017-04-18 | 2021-04-02 | 免疫医疗有限公司 | 吡咯并苯并二氮杂*缀合物 |
| WO2018193102A1 (en) | 2017-04-20 | 2018-10-25 | Adc Therapeutics Sa | Combination therapy with an anti-axl antibody-drug conjugate |
| CA3064804A1 (en) | 2017-06-14 | 2018-12-20 | Adc Therapeutics Sa | Dosage regimes for the administration of an anti-cd19 adc |
| KR102270107B1 (ko) | 2017-08-18 | 2021-06-30 | 메디뮨 리미티드 | 피롤로벤조디아제핀 컨쥬게이트 |
| NZ762505A (en) | 2017-09-29 | 2026-03-27 | Daiichi Sankyo Co Ltd | Antibody-pyrrolobenzodiazepine derivative conjugate |
| WO2019092148A1 (en) | 2017-11-10 | 2019-05-16 | Innate Pharma | Antibodies with functionalized glutamine residues |
| GB201803342D0 (en) | 2018-03-01 | 2018-04-18 | Medimmune Ltd | Methods |
| GB201806022D0 (en) | 2018-04-12 | 2018-05-30 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| CN113631560B (zh) | 2019-03-15 | 2025-02-18 | 麦迪穆有限责任公司 | 氮杂环丁烷并苯并二氮杂䓬二聚体和用于治疗癌症的包含它们的缀合物 |
| JP7593323B2 (ja) | 2019-09-26 | 2024-12-03 | 日油株式会社 | ペプチドリンカーを有するヘテロ二官能性単分散ポリエチレングリコール |
| AU2021251875A1 (en) | 2020-04-10 | 2022-11-03 | Seagen Inc. | Charge variant linkers |
| MX2023005873A (es) | 2020-11-25 | 2023-06-05 | Innate Pharma | Tratamiento del cancer. |
| CA3213625A1 (en) | 2021-03-18 | 2022-09-22 | Seagen Inc. | Selective drug release from internalized conjugates of biologically active compounds |
| BR112023018676A2 (pt) | 2021-03-18 | 2023-10-10 | Seagen Inc | Conjugado anticorpo-fármaco, composição farmacêutica, métodos de tratamento de uma doença ou condição e de um câncer, e, composição de conjugado ligante-fármaco |
| JP2025517476A (ja) | 2022-05-25 | 2025-06-05 | イナート・ファルマ・ソシエテ・アノニム | ネクチン－４結合剤 |
| WO2024129756A1 (en) | 2022-12-13 | 2024-06-20 | Seagen Inc. | Site-specific engineered cysteine antibody drug conjugates |
| CN117875311B (zh) * | 2024-01-11 | 2024-06-21 | 北京领初医药科技有限公司 | 一种缩略语句匹配方法、装置及存储介质 |
| WO2025149947A1 (en) | 2024-01-12 | 2025-07-17 | Seagen Inc. | Antibody-drug conjugates |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1516743A (fr) | 1966-04-01 | 1968-02-05 | Rhone Poulenc Sa | Nouvel antibiotique et son procédé de préparation par culture de streptomyces croceus |
| GB8307865D0 (en) * | 1983-03-22 | 1983-04-27 | Fujisawa Pharmaceutical Co | Benzimidazole derivatives |
| GB9205051D0 (en) * | 1992-03-09 | 1992-04-22 | Cancer Res Campaign Tech | Pyrrolobenzodiazepine derivatives,their preparation,and compositions containing them |
| KR19990029749A (ko) * | 1997-09-17 | 1999-04-26 | 미우라 아끼라 | 2가 반응성 수용성 고분자 유도체 및 이들을 함유하는 복합체 |
| GB9818731D0 (en) | 1998-08-27 | 1998-10-21 | Univ Portsmouth | Compounds |
| DE69925133T2 (de) | 1998-08-27 | 2006-01-19 | Spirogen Ltd., Ryde | Pyrrolobenzodiazepine |
| BR0210915A (pt) * | 2001-06-08 | 2004-06-08 | Sod Conseils Rech Applic | Análogos quiméricos de somatostatina-dopamina |
| US6716821B2 (en) | 2001-12-21 | 2004-04-06 | Immunogen Inc. | Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same |
| US7230101B1 (en) | 2002-08-28 | 2007-06-12 | Gpc Biotech, Inc. | Synthesis of methotrexate-containing heterodimeric molecules |
| ZA200503075B (en) | 2002-11-07 | 2006-09-27 | Immunogen Inc | Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same |
| MXPA05011811A (es) | 2003-05-20 | 2006-02-17 | Immunogen Inc | Agentes citotoxicos mejorados que comprenden nuevos maitansinoides. |
| ATE496944T1 (de) | 2003-07-21 | 2011-02-15 | Immunogen Inc | Ca6-antigenspezifisches zytotoxisches konjugat und verfahren zu dessen anwendung |
| WO2005040170A2 (en) | 2003-10-22 | 2005-05-06 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto |
| WO2005085260A1 (en) | 2004-03-09 | 2005-09-15 | Spirogen Limited | Pyrrolobenzodiazepines |
| EP1669358A1 (en) | 2004-12-07 | 2006-06-14 | Aventis Pharma S.A. | Cytotoxic agents comprising new taxanes |
| EP2399893B1 (en) | 2004-12-22 | 2018-08-15 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| EP1945647B9 (en) * | 2005-11-08 | 2012-11-14 | Immunogen, Inc. | Processes for preparation of maytansinol |
| RS52060B (sr) * | 2006-01-25 | 2012-04-30 | Sanofi | Citotoksični agensi koji sadrže nove derivate tomaimicina |
| EP1832577A1 (en) | 2006-03-07 | 2007-09-12 | Sanofi-Aventis | Improved prodrugs of CC-1065 analogs |
| US8212083B2 (en) | 2006-04-27 | 2012-07-03 | Intezyne Technologies, Inc. | Heterobifunctional poly(ethylene glycol) containing acid-labile amino protecting groups and uses thereof |
| EP1864682A1 (en) | 2006-06-09 | 2007-12-12 | Sanofi-Aventis | Leptomycin derivatives |
| MX2009000709A (es) * | 2006-07-18 | 2009-02-04 | Sanofi Aventis | Anticuerpo antagonista contra epha2 para el tratamiento de cancer. |
| EP1914242A1 (en) | 2006-10-19 | 2008-04-23 | Sanofi-Aventis | Novel anti-CD38 antibodies for the treatment of cancer |
| SI2019104T1 (sl) * | 2007-07-19 | 2013-12-31 | Sanofi | Citotoksična sredstva, ki obsegajo nove tomaimicinske derivate, in njihova terapevtska uporaba |
| US8865875B2 (en) | 2007-08-22 | 2014-10-21 | Medarex, L.L.C. | Site-specific attachment of drugs or other agents to engineered antibodies with C-terminal extensions |
| SG189817A1 (en) * | 2008-04-30 | 2013-05-31 | Immunogen Inc | Potent conjugates and hydrophilic linkers |
| RU2683325C2 (ru) * | 2009-02-05 | 2019-03-28 | Иммьюноджен, Инк. | Новые производные бензодиазепина |
| TW201117814A (en) * | 2009-10-02 | 2011-06-01 | Sanofi Aventis | New maytansinoids and the use of said maytansinoids to prepare conjugates with an antibody |
| FR2963007B1 (fr) * | 2010-07-26 | 2013-04-05 | Sanofi Aventis | Derives anticancereux, leur preparation et leur application therapeutique |
-
2009
- 2009-08-25 FR FR0904043A patent/FR2949469A1/fr active Pending
- 2009-09-11 FR FR0904368A patent/FR2949470B1/fr not_active Expired - Fee Related
-
2010
- 2010-08-12 MY MYPI2012000814A patent/MY157469A/en unknown
- 2010-08-12 MX MX2012002434A patent/MX2012002434A/es active IP Right Grant
- 2010-08-12 EP EP10761055.2A patent/EP2470547B1/fr active Active
- 2010-08-12 CN CN201080048398.6A patent/CN102753559B/zh active Active
- 2010-08-12 WO PCT/FR2010/051709 patent/WO2011023883A1/fr not_active Ceased
- 2010-08-12 PE PE2012000267A patent/PE20120992A1/es not_active Application Discontinuation
- 2010-08-12 KR KR1020127007518A patent/KR20130026405A/ko not_active Abandoned
- 2010-08-12 JP JP2012526097A patent/JP5889189B2/ja not_active Expired - Fee Related
- 2010-08-12 AU AU2010288382A patent/AU2010288382B2/en not_active Ceased
- 2010-08-12 ES ES10761055.2T patent/ES2484690T3/es active Active
- 2010-08-12 UA UAA201203443A patent/UA106507C2/uk unknown
- 2010-08-12 CA CA2772102A patent/CA2772102C/fr not_active Expired - Fee Related
- 2010-08-12 PH PH1/2012/500391A patent/PH12012500391A1/en unknown
- 2010-08-12 EA EA201270308A patent/EA026488B1/ru not_active IP Right Cessation
- 2010-08-12 BR BR112012004146A patent/BR112012004146A2/pt not_active Application Discontinuation
- 2010-08-12 NZ NZ598401A patent/NZ598401A/en not_active IP Right Cessation
- 2010-08-12 SG SG2012012431A patent/SG178537A1/en unknown
- 2010-08-23 AR ARP100103066A patent/AR078143A1/es unknown
- 2010-08-24 TW TW099128330A patent/TWI477275B/zh not_active IP Right Cessation
- 2010-08-24 UY UY0001032854A patent/UY32854A/es not_active Application Discontinuation
-
2012
- 2012-02-03 TN TNP2012000053A patent/TN2012000053A1/fr unknown
- 2012-02-08 DO DO2012000038A patent/DOP2012000038A/es unknown
- 2012-02-16 GT GT201200046A patent/GT201200046A/es unknown
- 2012-02-17 CR CR20120085A patent/CR20120085A/es unknown
- 2012-02-21 CO CO12029986A patent/CO6612210A2/es unknown
- 2012-02-22 IL IL218262A patent/IL218262A0/en unknown
- 2012-02-22 EC ECSP12011688 patent/ECSP12011688A/es unknown
- 2012-02-24 ZA ZA2012/01397A patent/ZA201201397B/en unknown
- 2012-02-24 HN HN2012000437A patent/HN2012000437A/es unknown
- 2012-02-24 US US13/404,872 patent/US8481042B2/en active Active
- 2012-02-24 CL CL2012000489A patent/CL2012000489A1/es unknown
- 2012-02-24 NI NI201200031A patent/NI201200031A/es unknown
- 2012-03-21 MA MA34711A patent/MA33600B1/fr unknown
-
2013
- 2013-06-05 CL CL2013001609A patent/CL2013001609A1/es unknown
- 2013-06-21 US US13/923,544 patent/US20140155590A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2013001609A1 (es) | Uso de compuestos fenil o piridin sustituidos como intermediarios para la preparacion de un compuesto conjugado de dimeros de pirrolo[1,4]benzodiazepina (pbd) (divisional de la solicitud 489-2012). | |
| DK2137184T3 (da) | Imidazo[1,2-a]pyridinforbindelser som receptor-tyrosinkinaseinhibitorer | |
| BRPI0822237A2 (pt) | Compostos de imidazo [1,2-a] piridina | |
| DK3106463T6 (da) | Pyrazolo[1,5-]pyrimidinforbindelse som trk-kinasehæmmer | |
| DK2384326T3 (da) | Pyrrolo[2,3-d]pyrimidinforbindelser | |
| DK2350075T3 (da) | Substituerede imidazo[1,2b]pyridazinforbindelser som trk-kinase-inhibitorer | |
| DK1904494T3 (da) | Imidazo[1,2-A]pyridin-forbindelser som VEGF-R2-inhibitorer | |
| DK2057154T3 (da) | PYRIDO-(2,3-B)pyrazinderivater, der er anvendelige som herbicidale forbindelser | |
| EP2525659A4 (en) | PYRAZOL- [1,5-A-] PYRIMIDINE COMPOUNDS AS AN ALKORM HEMMER | |
| CL2012003564A1 (es) | Compuestos derivados de heteroaril limidazolona :composición farmacéutica;uso de los compuestos para la inhibición de jak1,jak2 y jak3; y combinaciones farmacéuticas. | |
| CL2007001040A1 (es) | Proceso para la preparacion de antagonista de la sustancia p derivado de acil-amino-alquilen-amida. | |
| DK2201012T3 (da) | Pyrrolo[2,3-d]pyrimidinderivater som proteinkinase b-hæmmere | |
| DK2137196T3 (da) | Tricykliske nitrogenholdige forbindelser som antibakterielle midler | |
| IL213787A0 (en) | Substituted 5,6-dihydro-6-phenylbenzo[f] isoquinolin-2-amine compounds | |
| EP1732566A4 (en) | 6-azaindole COMPOUND | |
| BRPI0914802A2 (pt) | Composto, pró-droga, medicamento, uso do composto ou uma pró-droga de mesmo. | |
| BRPI0919292A2 (pt) | 3h-imidazo[4,5-b] piridina-6-carboxamidas como agentes anti-inflamatórios | |
| BRPI0822240A2 (pt) | Composto imidazo [1,2-b] piridazina como moduladores de receptores x hepáticos | |
| DK1710241T3 (da) | Intermediatforbindelser til fremstilling af trans-5-chlor-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol | |
| DK1954697T3 (da) | Peri-kondenserede tricykliske forbindelser, der er anvendelige som antibakterielle midler | |
| DK2124944T3 (da) | Pyrazolo[3,4-b]pyridinderivater som phosphodiesteraseinhibitorer | |
| BRPI0822239A2 (pt) | Composto de pirazolo[1,5-a] pirimidina | |
| ZA201004031B (en) | Dehydrohalagenation process for the preparation of intermediates useful in providing 6,6-dimethyl-3-azabicyclo-[3.1.0]-hexane compounds | |
| BRPI0813379A2 (pt) | Composto, composição farmacêutica, uso de um composto, e, método para modular atividade de um receptor de gabaa. | |
| EP2142542A4 (en) | NEW IMIDAZO [4,5-B] PYRIDINE-7-CARBOXYLAMIDEAMIDE 704 |